Press Releases

Page Category: 

THE VEVO LAZR PHOTOACOUSTICS IMAGING SYSTEM

NEW TECHNOLOGY IMPROVES DIAGNOSTICS AND THE DISCOVERY OF NEW THERAPEUTICS

The Vevo LAZR System Debuts at the American Association of Cancer Research (AACR) April 3-6, Orlando, Florida

TORONTO, Canada - March 24, 2011 - VisualSonics Inc. , a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc. , (Nasdaq:Sono), today announced the launch of the Vevo® LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market. This revolutionary technology combines the sensitivity of optical imaging with the resolution and depth penetration of high-frequency ultrasound, enabling researchers to study cancer in its earliest stages of progression and detect and evaluate tumor growth. For the first time, researchers will be able to observe tumor biology, measure hypoxia (oxygen levels), evaluate changes in blood flow, and quantify data with...

BOTHELL, WA - February 23, 2011 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for the point-of-care, today announced that Marcus Smith, Senior Vice President and Chief Financial Officer, will present at the Washington Biotechnology and Biomedical Association (WBBA) Life Science Innovation Northwest Conference. The conference will be held at the Washington State Convention Center in Seattle from March 2-3, 2011. Mr. Smith will be presenting on March 2nd at 9:30 a.m. Pacific Time.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

28% Fourth Quarter 2010 Revenue Growth 74% Fourth Quarter 2010 Ebitdas Growth

21% Full-Year 2010 Revenue Growth 60% Full-Year 2010 Ebitdas Growth

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA – February 17, 2011 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the fourth quarter and year ended December 31, 2010.

REVENUE Revenue for the fourth quarter was $89.3 million, an increase of 28% for the quarter. Full-year 2010 revenue reached $275.4 million compared to $227.4 million in 2009, an increase of 21%.

VisualSonics, Inc. revenue was $8.9 million for the quarter, representing the second consecutive strong performance since the company was acquired in June 2010.

SonoSite revenue, excluding VisualSonics, was $80.4 million, an increase of 15% compared to the fourth quarter of 2009, and $257.7 million for the full-year, an increase of 13%.

Foreign currency rates had negligible impacts on fourth quarter and full-year results.

HIGHLIGHTS

SonoSite Expands Its NBA D-League Partnership to Present the fifth NBA D-League All-Star Game which will take place at the Los Angeles Convention Center on Feb. 19 and air live on NBA TV

BOTHELL, WA – February 3, 2010 – The NBA Development League (NBA D-League) and SonoSite, Inc . (Nasdaq:SONO), today announced that the world leader and specialist in bedside and point-of-care ultrasound technology will become the presenting partner of the 2011 NBA D-League All-Star Game.

The fifth NBA D-League All-Star Game presented by SonoSite will take place at the Los Angeles Convention Center on Saturday, Feb. 19, broadcast live on NBA TV at 2:00 p.m. PST. As the presenting partner of the 2011 NBA D-League All-Star Game, SonoSite will have prominent exposure throughout Center Court at the NBA All-Star Jam Session presented by adidas. In addition, SonoSite will have portable ultrasound devices and trained staff available on the sidelines to treat players. SonoSite's President and CEO, Kevin Goodwin, will also present the MVP Award to the game's most valuable player during a postgame ceremony.

BOTHELL, WA - January 20, 2011 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that it will report the company’s fourth quarter and full-year financial results on Thursday, February 17, 2011 at the close of market and will host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

A replay of the audio webcast will be available beginning February 17th at 5:30 pm PT and will be available until March 3rd at 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 2745372 is required to access the replay. The call will also be archived on SonoSite’s website.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA – December 20, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.

The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

US Sector Achieves an All Time High in Quarterly Revenues of $40 Million, Up 35% VisualSonics (VSI) Acquisition Delivers Second Consecutive Strong Quarter Company Experienced Improving Momentum and Market Dynamics

BOTHELL, WA – January 10, 2011 – SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced preliminary revenue results for the fourth quarter and year ended December 31, 2010.

Revenue for the fourth quarter was approximately $89 million, an increase of 27% for the quarter. Full-year 2010 revenue reached $275 million compared to $227 million in 2009, an increase of 21%.

VisualSonics revenue was $8.8 million for the quarter, representing the second consecutive strong performance since the company was acquired in June 2010.

SonoSite revenue, excluding VSI, was approximately $80 million, an increase of 15% compared to the fourth quarter of 2009, and $257 million for the full-year, an increase of 13%.

BOTHELL, WA - December 20, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.

The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

US Revenue Up 17% International Revenue Up 7% VisualSonics Revenue Up 30% Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - October 21, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2010.

REVENUE Revenue increased 28% in the third quarter to $68.5 million and increased 18% for the nine months of 2010 to $186.1 million, as compared to the prior year.

Revenue included $8.7 million for the third quarter and nine months from the recently acquired VisualSonics (VSI).

Excluding VSI, revenue in the third quarter was $59.8 million, an increase of 12% compared to the third quarter of 2009, and $177.4 million, an increase of 12% for the nine months just ended.

Revolutionary portable technology provides dynamic assessment of soft tissue and bone injuries

BOTHELL, WA - October 21, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the National Basketball Association (NBA), announced today a multiyear agreement to introduce SonoSite's ultrasound technology to the NBA's medical and athletic training professionals.

As part of the agreement, SonoSite will be the preferred provider of ultrasound products to the NBA and the NBA Development League (NBA D-League). This relationship will educate the NBA and NBA D-League's team physicians and athletic trainers about SonoSite's unique diagnostic ultrasound tools that are highly portable and can assist in efficiently diagnosing, treating, and monitoring the rehabilitation of professional athletes.